Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Spectrum Pharma Inc (SPPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2002	12-2001	12-2000	12-1999	12-1998
Cash Flows From Operating Activities
Net Income	-17,634	-27,835	-46,427	-25,990	N/A
Depreciation Amortization	917	2,270	1,897	927	N/A
Other Working Capital	-1,941	209	36	2,359	N/A
Other Operating Activity	4,161	526	1,464	2,458	0
Operating Cash Flow	$-14,497	$-24,830	$-43,031	$-20,246	$N/A

Cash Flows From Investing Activities
Change In Deposits	6,209	-1,010	-2,317	-1,249	N/A
PPE Investments	63	-1,364	-369	-430	N/A
Other Investing Activity	0	-66	-301	412	0
Investing Cash Flow	$6,272	$-2,440	$-2,987	$-1,266	$N/A

Cash Flows From Financing Activities
Debt Issued	N/A	N/A	9,387	0	N/A
Debt Repayment	-653	-669	-476	-474	N/A
Common Stock Issued	9,921	28,329	29,988	24,143	N/A
Common Stock Repurchased	-143	N/A	N/A	N/A	N/A
Dividend Paid	N/A	-816	N/A	-136	N/A
Other Financing Activity	-136	-4,984	6,550	3,609	0
Financing Cash Flow	$8,989	$21,860	$45,450	$27,141	$N/A

Beginning Cash Position	748	6,158	6,726	1,097	N/A
End Cash Position	1,512	748	6,158	6,726	N/A
Net Cash Flow	$764	$-5,410	$-568	$5,629	$N/A

Free Cash Flow
Operating Cash Flow	-14,497	-24,830	-43,031	-20,246	N/A
Capital Expenditure	-59	-1,364	-369	-430	N/A
Free Cash Flow	-14,556	-26,194	-43,400	-20,676	0